Cargando…
Causal Effect of Fibroblast Growth Factor 23 on Osteoporosis and Cardiometabolic Disorders: A Mendelian Randomization Study
Pathological excess of fibroblast growth factor 23 (FGF23) causes mineral and bone disorders. However, the causality of FGF23 in the development of osteoporosis remains unknown. Whether FGF23 has systemic effects on cardio-metabolic disorders beyond regulating mineral metabolism is also controversia...
Autores principales: | Yokomoto-Umakoshi, Maki, Umakoshi, Hironobu, Miyazawa, Takashi, Ogata, Masatoshi, Sakamoto, Ryuichi, Ogawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089954/ http://dx.doi.org/10.1210/jendso/bvab048.552 |
Ejemplares similares
-
SUN-378 Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture
por: Sakamoto, Ryuichi, et al.
Publicado: (2020) -
THU418 Steroid Profiles And Its Implication In Bone Mass And Quality In Premenopausal Women With Adrenal Tumors With Autonomous Cortisol Secretion
por: Nakao, Hiroshi, et al.
Publicado: (2023) -
MON-204 Pheochromocytoma and Paraganglioma: An Emerging Cause of Secondary Osteoporosis
por: Yokomoto-Umakoshi, Maki, et al.
Publicado: (2020) -
SAT-551 Sparing Confirmatory Tests in Primary Aldosteronism
por: Umakoshi, Hironobu, et al.
Publicado: (2020) -
SAT-548 Significance of Adrenal Vein Aldosterone Gradient in the Diagnosis of Unilateral Subtype of Primary Aldosteronism
por: Ogata, Masatoshi, et al.
Publicado: (2020)